DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Serri O, Li L, Mamputu JC. et al.
The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy.
Clin Endocrinol (Oxf) 2006;
64: 366-370
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.